It is a food and beverages private limited company based in Hyderabad, Telangana, India, established in 2001.
2001 | Hyderabad, Telangana, India | ActiveDoxin Laboratories Private Limited, a active private limited company, was established on 23 August 2001 in Hyderabad, Telangana, India. Engaging in non-alcoholic beverage manufacturing & distribution within the manufacturing sector, it holds CIN: U24110TG2001PTC034430. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 Cr and a paid-up capital of ₹4.67 M.
It upholds a compliant status. Its leadership includes Ramakrishna Rao Veduruvada (Director), Narendra Kumar Veduruvada (Managing Director). Past directors included Yalamati Soumya, Phani Sushma Veduruvada. Its latest AGM occurred on 30 September 2022, with the balance sheet filed on 31 March 2022. It is based at 8-3-677/31 , First Floor Sri Krishna Devaraya Nagar , Yellareddyg, Uda, Hyderabad, Telangana, 500073.
U24110TG2001PTC034430
034430
23 August 2001
₹1.00 Cr
₹4.67 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Doxin Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramakrishna Rao Veduruvada | Director | 01 Feb 2010 | Current |
| Narendra Kumar Veduruvada | Managing Director | 24 Aug 2006 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Jun 2019 | Past |
| Pramod Abcsdd | Director | 10 Jun 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Doxin Laboratories Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 11.55% decrease. The company also saw a substantial improvement in profitability, with a 43.5% increase in profit. The company's net worth dipped by a decrease of 2.59%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Doxin Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Doxin Laboratories, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Doxin Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Doxin Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Doxin Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2022 as per latest MCA records. was recorded as a recent event.
Progress on Doxin Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2022 with Roc Hyderabad. was documented.
Ramakrishna Rao Veduruvada was appointed as a Director was appointed as a Director on 01 Feb 2010 & has been associated with this company since 15 years 10 months . was recorded as a recent event.
The activity Narendra Kumar Veduruvada was appointed as a Managing Director was appointed as a Managing Director on 24 Aug 2006 & has been associated with this company since 19 years 4 months . was completed.
The activity Doxin Laboratories Private Limited was registered on 23 Aug 2001 with Roc Hyderabad & aged 24 years 4 months as per MCA records. was completed.
The CIN of Doxin Laboratories Private Limited is U24110TG2001PTC034430.
Doxin Laboratories Private Limited is headquartered at 8-3-677/31 , First Floor Sri Krishna Devaraya Nagar , Yellareddyg, Uda, Hyderabad, Telangana, 500073.
Doxin Laboratories Private Limited was incorporated on 23 August 2001.
The current directors of Doxin Laboratories Private Limited are
The primary industry of Doxin Laboratories Private Limited is Manufacturing.
Doxin Laboratories Private Limited is unlisted.
The authorized capital of Doxin Laboratories Private Limited is ₹1.00 Cr, and the paid-up capital is ₹4.67 M.
The compliance status of Doxin Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX